IP Library Granted Patent US 9,040,101
Granted Patent B2
US 9,040,101 · App. 14/592,393 · Granted May 26, 2015

Method to treat diabetes utilizing a gastrointestinal microbiome modulating composition

Inventors: Mark L. Heiman (Indianapolis, IN); Dean P. Stull (Longmont, CO); Justin W Peno (Saint Francisville, LA)
Assignee: MicroBiome Therapeutics LLC.
A61K31/155A61K38/28A61K31/716A61K36/45A23L1/3002A23V2002/00A61K36/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,101
App. No.
14/592,393
Granted
May 26, 2015
Kind
B2
Abstract

Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure teaches compositions and methods for treating diabetes utilizing a gastrointestinal microbiome modulating composition.

Claims (47)

1. A method for treating diarrhea associated with administration of metformin in a diabetic human in need thereof, comprising:

a) administering to the diabetic human a pharmaceutical composition comprising a therapeutically effective amount of metformin; and

b) administering to the diabetic human a therapeutic composition, comprising a therapeutically effective amount of:

i. purified agave inulin;

ii. β-glucan extracted from oat; and

iii. blueberry pomace extract comprising at least one polyphenolic compound,

to effectively treat the diarrhea in the diabetic human.

2. The method according to claim 1 , comprising at least about 3 grams purified agave inulin.

3. The method according to claim 1 , comprising at least about 2 grams β-glucan extracted from oat.

4. The method according to claim 1 , wherein the extracted β-glucan is oat (1,3/1,4) β-glucan.

5. The method according to claim 1 , wherein the blueberry pomace extract comprises at least about 700 mg total polyphenolics.

6. The method according to claim 1 , wherein the blueberry pomace extract comprises anthocyanin.

7. The method according to claim 1 , wherein the therapeutic composition comprises:

i. at least about 3 grams purified agave inulin;

ii. at least about 2 grams β-glucan extracted from oat; and

iii. blueberry pomace extract comprising at least about 700 mg total polyphenolics.

8. The method according to claim 1 , wherein the therapeutic composition is formulated as a: medical food, beverage, suspension, powder, bar, smoothie, yogurt, shake, capsule, or tablet.

9. The method according to claim 1 , wherein said pharmaceutical composition and said therapeutic composition are formulated together as a combination and administered simultaneously.

10. The method according to claim 1 , wherein the therapeutic composition is administered orally to said diabetic human at least once per day, or at least twice per day, or at least three times per day.

11. The method according to claim 1 , wherein said diabetic human has Type 1 diabetes.

12. The method according to claim 1 , wherein said diabetic human has Type 2 diabetes.

13. The method according to claim 1 , wherein said diabetic human experiences less episodes of diarrhea when administered the therapeutic composition, as compared to the number of episodes of diarrhea experienced by said diabetic human when not administered the therapeutic composition.

14. The method according to claim 1 , wherein said diabetic human has less watery stool.

15. A method for treating diarrhea in a diabetic human in need thereof, comprising:

a) administering to the diabetic human a therapeutically effective amount of:

metformin, purified agave inulin, oat glucan extract, and blueberry pomace extract,

to effectively treat the diarrhea in the diabetic human.

16. The method according to claim 15 , wherein at least about 3 grams purified agave inulin is administered.

17. The method according to claim 15 , wherein the oat glucan extract is oat (1,3/1,4) β-glucan.

18. The method according to claim 15 , wherein at least about 2 grams oat glucan extract is administered.

19. The method according to claim 15 , wherein the blueberry pomace extract comprises at least one polyphenolic compound.

20. The method according to claim 15 , wherein the blueberry pomace extract comprises anthocyanin.

21. The method according to claim 15 , wherein the blueberry pomace extract comprises at least about 700 mg total polyphenolics.

22. The method according to claim 15 , wherein the purified agave inulin, oat glucan extract, and blueberry pomace extract are formulated together as a: medical food, beverage, suspension, powder, bar, smoothie, yogurt, shake, capsule, or tablet.

23. The method according to claim 15 , wherein said diabetic human has Type 1 diabetes.

24. The method according to claim 15 , wherein said diabetic human has Type 2 diabetes.

25. The method according to claim 15 , wherein said diabetic human experiences reduced episodes of diarrhea.

26. The method according to claim 15 , wherein said diabetic human experiences less watery stool.

27. A method to reduce diarrhea in a Type 2 diabetic human taking a therapeutically effective amount of metformin, comprising:

a) administering to the Type 2 diabetic human taking metformin, a therapeutically effective amount of a dietary gastrointestinal microbiome modulating composition, comprising, per dose:

i. at least about 3 grams purified agave inulin;

ii. at least about 2 grams oat glucan extract; and

iii. blueberry pomace extract comprising at least about 700 mg total polyphenolics,

wherein said Type 2 diabetic patient experiences reduced episodes of diarrhea.

28. The method according to claim 27 , wherein the oat glucan extract is oat (1,3/1,4) β-glucan.

29. The method according to claim 27 , wherein the dietary gastrointestinal microbiome modulating composition is administered orally to the Type 2 diabetic patient at least once per day, or twice per day, or three times per day.

30. The method according to claim 27 , wherein the dietary gastrointestinal microbiome modulating composition is formulated as a: medical food, beverage, suspension, powder, bar, smoothie, yogurt, shake, capsule, or tablet.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2020
From: MICROBIOME THERAPEUTICS, LLC
To: THE NATURE'S BOUNTY CO.
Reel/Frame 052426/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2015
From: HEIMAN, MARK L; STULL, DEAN P; PENO, JUSTIN W
To: NUME HEALTH LLC
Reel/Frame 034926/0335 →
CHANGE OF NAME Recorded Feb 10, 2015
From: NUME HEALTH LLC
To: MICROBIOME THERAPEUTICS LLC
Reel/Frame 034933/0819 →
Continuity (3)
Continuation 14238980
Provisional Application 61524524 · Aug 17, 2011
Related Publication 20150118330A1 · Apr 30, 2015